Validity of Takeda's Diabetes Drug Patent Upheld by Fed. Cir.
Takeda, Lilly jury awards $9 billion over hiding Actos risks | Mint
Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact | Fierce Biotech
Takeda veräußert vier Diabetes-Produkte in Japan an Teijin Pharma Limited | Business Wire
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JIWT4VMMFZMYNIVD3VNO6F4G7A.jpg "Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 bln | Reuters")
Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 bln | Reuters
Takeda har succes med diabetes-forsøg
2º Fórum Takeda Diabetes e TCA – Apps bei Google Play
Japan's Takeda agrees to pay $2.4B ln in diabetes drug suit
Takeda's Oral Medication Actos Goes Generic, Making it Significantly Cheaper
France pulls Takeda diabetes drugs after cancer fears | Pharmafile
Takeda venderá produtos de diabetes no Japão para Teijin Pharma Limited
35 Takeda Pharmaceuticals Actos Bilder und Fotos - Getty Images
Takeda Launches Three New Diabetes Treatments - MPR
Primary care and OTC products/Takeda Belgium
Takeda announces new access to medicines for Africa from Nairobi
Takeda ordered to pay record $6bn over diabetes drug claim | Financial Times
Takeda on Twitter: "#DYK: The rate of Type 2 #diabetes is higher in urban areas than rural areas. https://t.co/JBI3E9JkAL" / Twitter
Takeda | Das Informationsportal für die Pharmaproduktion, Management & Technik
Takeda loses cancer suit over Actos | The Japan Times
Court awards $6bn to cancer patient over Takeda's diabetes drug | The Times
Takeda Advances Diabetes Drug Development at the ALS
Takeda to sell diabetes products portfolio to Teijin Pharma for $1.25bn
